CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 843845-844001 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T15913","span":{"begin":0,"end":156},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Although pharmacogenomics holds great promise for individualized therapy in MS, big efforts should first be made to identify markers for treatment efficacy."}

{"project":"Epistemic_Statements","denotations":[{"id":"T1850","span":{"begin":0,"end":156},"obj":"Epistemic_statement"}],"text":"Although pharmacogenomics holds great promise for individualized therapy in MS, big efforts should first be made to identify markers for treatment efficacy."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T36","span":{"begin":0,"end":156},"obj":"Sentence"}],"text":"Although pharmacogenomics holds great promise for individualized therapy in MS, big efforts should first be made to identify markers for treatment efficacy."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T3527","span":{"begin":76,"end":78},"obj":"Body_part"}],"attributes":[{"id":"A3527","pred":"uberon_id","subj":"T3527","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"Although pharmacogenomics holds great promise for individualized therapy in MS, big efforts should first be made to identify markers for treatment efficacy."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5318","span":{"begin":76,"end":78},"obj":"Disease"},{"id":"T54091","span":{"begin":76,"end":78},"obj":"Disease"}],"attributes":[{"id":"A5318","pred":"mondo_id","subj":"T5318","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A80322","pred":"mondo_id","subj":"T54091","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"Although pharmacogenomics holds great promise for individualized therapy in MS, big efforts should first be made to identify markers for treatment efficacy."}